• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺移植术后上、下呼吸道微生物群的特征

Characteristics of upper and lower respiratory tract microbiota after lung transplantation.

作者信息

Cai Yuhang, Fan Yuchen, Chen Ao, Wang Xiaohua, Wang Lulin, Chen Jiaqi, Wang Zhang, Li Jia, Yi Xinzhu, Ju Chunrong

机构信息

State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guang Dong, China.

Institute of Ecological Sciences, School of Life Sciences, South China Normal University, Guangzhou, Guang Dong, China.

出版信息

Respir Res. 2025 Apr 25;26(1):160. doi: 10.1186/s12931-025-03235-4.

DOI:10.1186/s12931-025-03235-4
PMID:40281571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12023598/
Abstract

BACKGROUND

The composition and characteristics of airway microbiota offer critical insights for clinical decision-making. Current research on chronic lung diseases shows differences in the composition and characteristics of upper and lower respiratory tract microbiota compared with healthy individuals. However, the temporal changes of these microbial communities in lung transplant recipients remain poorly characterized.

METHODS

This is a longitudinal prospective study. Respiratory specimens were collected regularly from lung transplant recipients for testing and analysis. A total of 150 bronchoalveolar lavage fluid (BALF) samples, 150 throat swab samples, 51 sputum samples, and 36 lung tissue samples were collected from the recipients, at 7 days, 14 days, 1 month, 2 months, 3 months, and 6 months post-transplant for 16S rRNA gene sequencing and analysis.

RESULTS

Our study showed that there were significant differences in α-diversity and β-diversity among lung tissue, throat swab, and sputum samples, although α-diversity did not show a significant difference between lung tissue and BALF. Most amplicon sequence variants (ASVs) belonged to the families Enterobacteriaceae, Pseudomonadaceae, and Stenotrophomonas in BALF, while most ASVs belonged to the genera Streptococcus, Pseudomonadaceae, and Stenotrophomonas in sputum samples. Regarding dynamic changes, Corynebacterium and Staphylococcus were more prevalent in the early post-operative period but gradually decreased by 7 days post-operatively, while the common microbiota found in healthy populations based on literature became the most abundant ASVs at 6 months post-operatively in our study participants. Pseudomonadaceae and Stenotrophomonas contributed to the similarity in the composition of upper and lower respiratory microbiota.

CONCLUSIONS

This study demonstrates that lung transplant recipients exhibit unique characteristics in their upper and lower respiratory tract microbiota, which are distinct ecological profiles, and both undergo significant changes within 6 months post-operatively. The similarity between upper and lower respiratory tract microbiota is associated with microbial diversity and taxonomic dominance.

CLINICAL TRIAL

The clinical trial was registered at Chinese Clinical Trial Registry (ChiCTR2200056908) in February 2022.

摘要

背景

气道微生物群的组成和特征为临床决策提供了关键见解。目前关于慢性肺部疾病的研究表明,与健康个体相比,上、下呼吸道微生物群的组成和特征存在差异。然而,肺移植受者中这些微生物群落的时间变化仍未得到充分描述。

方法

这是一项纵向前瞻性研究。定期从肺移植受者中采集呼吸道标本进行检测和分析。在移植后7天、14天、1个月、2个月、3个月和6个月,从受者中总共采集了150份支气管肺泡灌洗液(BALF)样本、150份咽拭子样本、51份痰液样本和36份肺组织样本,用于16S rRNA基因测序和分析。

结果

我们的研究表明,肺组织、咽拭子和痰液样本之间的α多样性和β多样性存在显著差异,尽管肺组织和BALF之间的α多样性没有显著差异。BALF中大多数扩增子序列变体(ASV)属于肠杆菌科、假单胞菌科和嗜麦芽窄食单胞菌科,而痰液样本中大多数ASV属于链球菌属、假单胞菌科和嗜麦芽窄食单胞菌属。关于动态变化,棒状杆菌属和葡萄球菌属在术后早期更为普遍,但在术后7天时逐渐减少,而根据文献,健康人群中常见的微生物群在我们的研究参与者术后6个月时成为最丰富的ASV。假单胞菌科和嗜麦芽窄食单胞菌属导致了上、下呼吸道微生物群组成的相似性。

结论

本研究表明,肺移植受者的上、下呼吸道微生物群具有独特的特征,这是不同的生态特征,并且在术后6个月内均发生显著变化。上、下呼吸道微生物群之间的相似性与微生物多样性和分类优势有关。

临床试验

该临床试验于2022年2月在中国临床试验注册中心(ChiCTR2200056908)注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c444/12023598/cb935aaf773b/12931_2025_3235_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c444/12023598/07de18d07032/12931_2025_3235_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c444/12023598/d0b261f2a5ac/12931_2025_3235_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c444/12023598/553e022c5c56/12931_2025_3235_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c444/12023598/83d73dffae92/12931_2025_3235_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c444/12023598/cb935aaf773b/12931_2025_3235_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c444/12023598/07de18d07032/12931_2025_3235_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c444/12023598/d0b261f2a5ac/12931_2025_3235_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c444/12023598/553e022c5c56/12931_2025_3235_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c444/12023598/83d73dffae92/12931_2025_3235_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c444/12023598/cb935aaf773b/12931_2025_3235_Fig5_HTML.jpg

相似文献

1
Characteristics of upper and lower respiratory tract microbiota after lung transplantation.肺移植术后上、下呼吸道微生物群的特征
Respir Res. 2025 Apr 25;26(1):160. doi: 10.1186/s12931-025-03235-4.
2
Comparison of the upper and lower airway microbiome in early postoperative lung transplant recipients.比较早期肺移植术后患者上、下呼吸道微生物组。
Microbiol Spectr. 2024 Jun 4;12(6):e0379123. doi: 10.1128/spectrum.03791-23. Epub 2024 May 15.
3
Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort study.肺微生物组预测健康肺移植受者的慢性排斥反应:一项前瞻性队列研究。
Lancet Respir Med. 2021 Jun;9(6):601-612. doi: 10.1016/S2213-2600(20)30405-7. Epub 2021 Jan 15.
4
Divergent airway microbiomes in lung transplant recipients with or without pulmonary infection.肺移植受者中有无肺部感染的气道微生物组存在差异。
Respir Res. 2021 Apr 23;22(1):118. doi: 10.1186/s12931-021-01724-w.
5
Microbiome and metabolome patterns after lung transplantation reflect underlying disease and chronic lung allograft dysfunction.肺移植后微生物组和代谢组模式反映了潜在疾病和慢性肺移植物功能障碍。
Microbiome. 2024 Oct 9;12(1):196. doi: 10.1186/s40168-024-01893-y.
6
Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.慢性阻塞性肺疾病上呼吸道微生物群落 α 多样性与加重表型相关:一项病例对照观察性研究。
Respir Res. 2019 Jun 7;20(1):114. doi: 10.1186/s12931-019-1080-4.
7
Insights into the Unique Lung Microbiota Profile of Pulmonary Tuberculosis Patients Using Metagenomic Next-Generation Sequencing.利用宏基因组下一代测序技术深入了解肺结核患者独特的肺部微生物组特征。
Microbiol Spectr. 2022 Feb 23;10(1):e0190121. doi: 10.1128/spectrum.01901-21.
8
Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics.慢性阻塞性肺疾病上呼吸道微生物群与某些临床特征有关。
PLoS One. 2019 Jul 23;14(7):e0219962. doi: 10.1371/journal.pone.0219962. eCollection 2019.
9
Characterization of the upper and lower respiratory tract microbiota in Piedmontese calves.皮埃蒙特犊牛上呼吸道和下呼吸道微生物组的特征。
Microbiome. 2017 Nov 21;5(1):152. doi: 10.1186/s40168-017-0372-5.
10
A prevalent and culturable microbiota links ecological balance to clinical stability of the human lung after transplantation.一种普遍存在且可培养的微生物群将生态平衡与人类肺部移植后的临床稳定性联系起来。
Nat Commun. 2021 Apr 9;12(1):2126. doi: 10.1038/s41467-021-22344-4.

本文引用的文献

1
Lung Transplant Outcomes Keep BUGging us: Acute Cellular Rejection and the Lung Microbiome.肺移植结果一直困扰着我们:急性细胞排斥反应与肺微生物群
Am J Respir Crit Care Med. 2024 Jun 15;209(12):1423-1425. doi: 10.1164/rccm.202403-0499ED.
2
Alterations of lung microbiota in lung transplant recipients with pneumocystis jirovecii pneumonia.肺移植受者肺囊虫肺炎的肺微生物组改变。
Respir Res. 2024 Mar 14;25(1):125. doi: 10.1186/s12931-024-02755-9.
3
The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic Rejection.
肺微生物组可预测慢性排斥反应肺移植受者的死亡率和阿奇霉素反应。
Am J Respir Crit Care Med. 2024 Jun 1;209(11):1360-1375. doi: 10.1164/rccm.202308-1326OC.
4
Pseudomonas-dominant microbiome elicits sustained IL-1β upregulation in alveolar macrophages from lung transplant recipients.假单胞菌占优势的微生物组会引起肺移植受者肺泡巨噬细胞中持续的 IL-1β 上调。
J Heart Lung Transplant. 2023 Sep;42(9):1166-1174. doi: 10.1016/j.healun.2023.04.005. Epub 2023 Apr 21.
5
Multidrug-resistant organisms in lung transplant: a narrative review.肺移植中的耐多药病原体:叙述性综述。
Curr Opin Organ Transplant. 2023 Jun 1;28(3):174-179. doi: 10.1097/MOT.0000000000001066. Epub 2023 Mar 28.
6
Interventional pulmonology techniques in lung transplantation.肺移植中的介入肺脏病学技术。
Respir Med. 2023 May;211:107212. doi: 10.1016/j.rmed.2023.107212. Epub 2023 Mar 15.
7
The dynamic lung microbiome in health and disease.健康与疾病中的动态肺部微生物组。
Nat Rev Microbiol. 2023 Apr;21(4):222-235. doi: 10.1038/s41579-022-00821-x. Epub 2022 Nov 16.
8
An exploratory analysis of the lung microbiome and immune status in lung transplant recipients.肺移植受者肺部微生物群和免疫状态的探索性分析。
J Infect. 2022 Aug;85(2):e44-e46. doi: 10.1016/j.jinf.2022.05.031. Epub 2022 Jun 1.
9
Comparison of microbiota in the upper versus lower respiratory tract in children during health and respiratory disease: protocol for a systematic review.比较健康儿童和患呼吸道疾病儿童上呼吸道与下呼吸道的微生物群:系统综述方案。
Syst Rev. 2021 Sep 21;10(1):253. doi: 10.1186/s13643-021-01806-2.
10
Advances in Human Lung Transplantation.人类肺移植的进展。
Annu Rev Med. 2021 Jan 27;72:135-149. doi: 10.1146/annurev-med-080119-103200. Epub 2020 Oct 28.